541 "Do Surgeons performing cytoreductive therapy, such as HPEC and PIPAC, in peritoneal cancer patients adress troubled sexual health in disease-management-programs? Igls-Vienna-SexMed-Survey-Program: Participants' self-assessment-results at the HIPEC/PIPAC-Symposium, Salzburg, November 2017

Abstract

Hypertherme peritoneal chemoperfusion, HIPEC, as well as pressurized intraperitoneal aerosol chemotherapy, PIPAC, have an impact on pelvine structures and reproductive organs during surgical procedure in cancer patients. Due to chemotoxicity, heat as well as surgery, not always be performable in a nerve-sparing way in order to reduce cancer-cells sexual health can be heavily troubled in these patients. Life-expectancy of patients increases after successful therapy. Thus, the importance of their quality of life, living with cancer and sexual health increases, too. HIPEC/PIPAC are mainly offered in defined centers providing multidisciplinary, –professional expertise and high-end health care structures to be able to treat patients state-of-the-art. Little is known about these cancer patients’ sexual health. Thus, at the HIPEC/PIPAC-symposium, Salzburg, November 2017, 10 of 53 surgeons (19,86%) from Austria and Germany, accepted the invitation to participate in the Igls-Vienna-SexMed-Survey-Program and self-assess the integration of sexual health in their patient-management-concepts via questionnaire.